{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:00:53Z","timestamp":1793736053280,"version":"4.6.1"},"reference-count":62,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T00:00:00Z","timestamp":1273104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2011,5]]},"abstract":"<jats:p>Cutaneous adverse drug reactions range from mild to severe and from those localized only to skin to those associated with systemic disease. It is important to distinguish features of cutaneous drug reactions which help classify the underlying mechanism and likely prognosis as both of these influence management decisions, some of which necessarily have to be taken rapidly. Severe cutaneous reactions are generally T cell\u2010mediated, yet this immunological process is frequently poorly understood and principles for identification of the culprit drug are different to those of IgE mediated allergic reactions. Furthermore, intervention in severe skin manifestations of drug allergy is frequently necessary. However, a substantial literature reports on success or otherwise of glucocorticoids, cyclophsphamide, ciclosporin, intravenous immunoglobulin and anti\u2010tumour necrosis factor therapy for the treatment of toxic epidermal necrolysis without clear consensus. As well as reviewing the recommended supportive measures and evidence base for interventions, this review aims to provide a mechanistic overview relating to a proposed clinical classification to assist the assessment and management of these complex patients.<\/jats:p>","DOI":"10.1111\/j.1365-2125.2010.03703.x","type":"journal-article","created":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T15:05:02Z","timestamp":1273158302000},"page":"672-683","source":"Crossref","is-referenced-by-count":67,"title":["Skin manifestations of drug allergy"],"prefix":"10.1111","volume":"71","author":[{"given":"Michael R.","family":"Ardern\u2010Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Friedmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,4,11]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1986.03380240052027"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1997.tb01017.x"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2003.05584.x"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1992.tb05647.x"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1085-5629(96)80035-6"},{"key":"e_1_2_8_7_2","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0022-3565(25)24104-0","article-title":"Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane","volume":"245","author":"Kenna JG","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199002000-00004"},{"key":"e_1_2_8_9_2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0026-895X(25)08704-8","article-title":"Epitope mapping studies with human anti\u2010cytochrome P450 3A antibodies","volume":"49","author":"Leeder JS","year":"1996","journal-title":"Mol Pharmacol"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.155.1.462"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.63.3.732"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701071"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.03.005"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.1507"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/334395a0"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5441.958"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1071059"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.11.5.2804"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0962-8924(91)90072-H"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1991.tb07761.x"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.21.16023"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R900010200"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07873-X"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409500102"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/428486a"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0307067101"},{"key":"e_1_2_8_27_2","first-page":"576","volume-title":"Clinical Aspects of Immunology","author":"Coombs RRA","year":"1968"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1159\/000104199"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra066469"},{"key":"e_1_2_8_30_2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1684\/ejd.2010.0891","article-title":"Drug\u2010induced exanthemata: a source of clinical and intellectual confusion","volume":"20","author":"Friedmann PS","year":"2010","journal-title":"European Journal Dermatology"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2006.03.010"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07332.x"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.55.1"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.8.1019"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00061.x"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06721.x"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411103311906"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006534-199809020-00014"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.08.039"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)80969-3"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.2576n.x"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-200003000-00017"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5388.490"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.55.9"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1159\/000070957"},{"key":"e_1_2_8_46_2","first-page":"459","article-title":"Soluble fractions of tumor necrosis factor\u2010alpha, interleukin\u20106 and of their receptors in toxic epidermal necrolysis: a comparison with second\u2010degree burns","volume":"1","author":"Paquet P","year":"1998","journal-title":"Int J Mol Med"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.6.1675"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)02197-7"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.46833.x"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.06.029"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0462"},{"key":"e_1_2_8_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2009.00616.x"},{"key":"e_1_2_8_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2009.03480.x"},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630802683843"},{"key":"e_1_2_8_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1997.tb03795.x"},{"key":"e_1_2_8_56_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.9.1108"},{"key":"e_1_2_8_57_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.9.1113"},{"key":"e_1_2_8_58_2","unstructured":"FriedmannPS Ardern\u2010JonesM.Patch testing in drug allergy.Curr Opin Allergy Clin Immunol2010; May 18 [Epub ahead of print]."},{"key":"e_1_2_8_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2004.12.024"},{"key":"e_1_2_8_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1997.tb00690.x"},{"key":"e_1_2_8_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01553.x"},{"key":"e_1_2_8_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.03933.x"},{"key":"e_1_2_8_63_2","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e32833aa54d"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.2010.03703.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.2010.03703.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T16:56:45Z","timestamp":1740070605000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.2010.03703.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,11]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.1111\/j.1365-2125.2010.03703.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.2010.03703.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,11]]}}}